Free Trial
NASDAQ:WBA

Walgreens Boots Alliance Q3 2025 Earnings Report

Walgreens Boots Alliance logo
$11.61 +0.02 (+0.17%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$11.60 -0.01 (-0.13%)
As of 08:48 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Walgreens Boots Alliance EPS Results

Actual EPS
$0.38
Consensus EPS
$0.34
Beat/Miss
Beat by +$0.04
One Year Ago EPS
$0.63

Walgreens Boots Alliance Revenue Results

Actual Revenue
$38.99 billion
Expected Revenue
$36.72 billion
Beat/Miss
Beat by +$2.27 billion
YoY Revenue Growth
+7.20%

Walgreens Boots Alliance Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
Thursday, June 26, 2025
Conference Call Time
7:00AM ET

Earnings Documents

Walgreens Boots Alliance Earnings Headlines

Trump’s return could trigger this gold market shift
A Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your IRA could be at risk. Here’s how to prepare.
See More Walgreens Boots Alliance Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Walgreens Boots Alliance? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Walgreens Boots Alliance and other key companies, straight to your email.

About Walgreens Boots Alliance

Walgreens Boots Alliance (NASDAQ:WBA) operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.

View Walgreens Boots Alliance Profile

More Earnings Resources from MarketBeat